Circadian gatekeepers of the gut–brain–immune axis: implications for neuroinflammation and neurodegeneration Authors: Wai-Yin Cheng, Po-Lam Chan, Man-Ka Chan, Jiaying Xu, Ka-Hing Wong, Raymond Chuen-Chung Chang Published: 2026 ABSTRACT Circadian rhythms, primarily regulated by light–dark cycles, play a crucial role in maintaining physiological health, including metabolism and immune responses. Evidence shows that circadian rhythms are involved in modulating gut microbiota composition, peripheral and central immune systems, and neurodegenerative disease progression. Recent research has illuminated the complex interplay between circadian rhythms and the gut microbiota-immune-brain axis. This review examines the bidirectional relationship between circadian rhythms and gut microbiota, and explores how this interaction influences brain function through the gut-brain axis, with particular focus on neuroinflammation and neurodegeneration. We aim to provide novel insights that could inform therapeutic strategies to prevent or slow down the progression of neurodegenerative diseases through circadian rhythm modulation. Introduction Circadian rhythms are endogenous biological oscillations with a period of approximately 24 h. These rhythms are primarily regulated by light–dark cycles and other external factors. The retina captures changes in light intensity throughout the day, transmitting these signals to various brain regions responsible for regulating circadian rhythms [1]. In general, four key physiological functions are regulated by circadian rhythms: sleep and wakefulness,metabolic regulation, including energy balance, glucose metabolism, and appetite regulation; mood and mental health; and immune function [2–6]. Circadian disruption has been associated with an increased risk of developing neurologic, psychiatric, cardiometabolic, and immune disorders [7]. A common sign of circadian disruption is circadian rhythm sleep–wake disorder (CRSWD), where the endogenous circadian timing of the sleep–wake cycle becomes desynchronized with the external environment [8]. People with CRSWD often shown typical and broad sleep disturbance features, such as delayed or advanced sleep timing, sleep fragmentation, and daytime sleepiness and fatigue [9]. Several studies have reported that patients with dementia also experienced sleep disturbances even prior the onset of cognitive symptoms [10–12]. Indeed, sleep disturbance were shown to increase amyloid-beta (Aβ) accumulation, which is one of the cause of Alzheimer’s disease (AD), and promote neuroinflammation due to clearance failure, thus increase the risk of cognitive impairment [13–15]. Shift work, particularly night and rotating shift, creates chronic circadian misalignment, in which a cross-sectional analysis from the Canadian Longitudinal Study on Aging discovered that night shift work and rotating shift work were shown to increase the risk of cognitive impairment [16]. One potential mechanism linking circadian disruption to neurodegeneration involves the gut microbiota and systemic inflammation [17–19]. This review summarizes evidence that circadian rhythms act as gatekeepers of the gut–brain–immune axis, shaping daily oscillations in gut microbial composition and immune signaling. We highlight how circadian misalignment can disrupt host–microbe rhythmicity, promote dysbiosis, and exacerbate systemic inflammation, thereby contributing to neuroinflammation and cognitive impairment. We then summarize key mechanistic links spanning microbial metabolites and immune mediators to neuroinflammation, and discuss potential chronotherapeutic interventions for managing neurodegeneration in at-risk populations such as shift workers. Circadian rhythms Zeitgebers and regulation of circadian rhythms Circadian rhythms are natural biological oscillators within a living organism, allowing time-tracking over a 24-h cycle. There are two types of oscillators controlling the circadian rhythms: central and peripheral oscillators. The primary central oscillator is a paired nucleus located in the hypothalamus of humans, named the suprachiasmatic nucleus (SCN). The SCN acts as a master regulator, coordinating the rhythms of peripheral oscillators throughout the body and ensuring that various tissue cells maintain a synchronized oscillation phase [20]. Circadian rhythms are regulated by external stimuli known as zeitgebers, with the light–dark cycle being the most prominent example [1]. While circadian rhythms are naturally affected by sunrise and sunset, artificial light sources from electrical devices in modern society also affect their regulation. In addition to light, studies have identified diet [21], exercise [22], non-photic environmental cues such as social interactions and temperature [23, 24] also act as zeitgebers to adjust circadian rhythms. Daily activities and behaviors are bidirectionally linked to circadian rhythms. Endogenous circadian oscillators generate near-24‑hour rhythms that anticipate recurring environmental and behavioral events, allowing organisms to proactively adjust physiological set points, such as hormone secretion, body temperature, and metabolic activity, in preparation for predictable daily activities like feeding and sleeping [25, 26]. Simultaneously, these rhythms synchronize to external zeitgebers that reset the internal clock to align physiological responses with the external environment. Interestingly, this bidirectional relationship means that circadian rhythms regulate eating, sleep, thermoregulation, learning, and memory [27], while these same behaviors reciprocally entrain and adjust the circadian rhythms [25]. Molecular mechanism of circadian rhythms The regulation of circadian rhythms is fundamentally driven by a balance between the expression of activator and repressor genes and proteins, as illustrated in Fig. 1. At a molecular level, the process begins with the translation of the circadian locomotor output cycles kaput (Clock) and brain and muscle-Arnt-like 1 (Bmal1) genes into CLOCK and BMAL1 proteins, which form a heterodimer [3, 28]. It then subsequently binds to the promoter of target genes, including Period (Per1, Per2, and Per3) and Cryptochrome (Cry1 and Cry2). PER and CRY proteins work as a complex and translocate to the nucleus. It negatively regulates CLOCK/BMAL1-mediated gene expression, creating a 24-h rhythm [3, 29]. In humans, CLOCK and BMAL1 proteins form a heterodimeric complex that peaks during the day, activating the transcription of Per and Cry genes. PER and CRY proteins accumulate during the day, reach peak levels in the evening, and then enter the nucleus at night to repress CLOCK/BMAL1 activity. In addition, BMAL1 expression is regulated by two other nuclear receptors. BMAL1 expression can be suppressed by the REV-ERB (α and β) family and activated by ROR (α, β, and γ) families by binding to the promoter of BMAL1 [30, 31]. PER proteins undergo progressive phosphorylation by casein kinases 1 delta (CK1δ) and epsilon (CK1ε), which triggers their subsequent ubiquitin-mediated degradation. This degradation is crucial for determining the circadian clock period [32–35]. The complex regulatory mechanisms ensure the precise timing and self-sustaining nature of the circadian rhythm.Fig. 1The core molecular clock behind circadian rhythms. The regulation of circadian rhythms involves a balance between activator and repressor genes and proteins. The CLOCK and BMAL1 proteins form a heterodimeric complex that binds to the promoters of Per and Cry genes, activating their transcription. As PER and CRY proteins accumulate, they form complexes that translocate to the nucleus and inhibit CLOCK/BMAL1-mediated transcription, creating a negative feedback loop. Therefore, the expression of the CLOCK/BMAL1 complex follows a rhythmic pattern. In a secondary regulatory loop, the REV-ERB and ROR nuclear receptor families play critical roles in the regulation of Bmal1 expression, thus influencing circadian rhythmicity. Additionally, CK1δ and CK1ε are involved in the post-translational modification of PER and CRY. This phosphorylation process facilitates the subsequent degradation of PER and CRY, thereby maintaining the 24-h circadian cycle The core molecular clock behind circadian rhythms. The regulation of circadian rhythms involves a balance between activator and repressor genes and proteins. The CLOCK and BMAL1 proteins form a heterodimeric complex that binds to the promoters of Per and Cry genes, activating their transcription. As PER and CRY proteins accumulate, they form complexes that translocate to the nucleus and inhibit CLOCK/BMAL1-mediated transcription, creating a negative feedback loop. Therefore, the expression of the CLOCK/BMAL1 complex follows a rhythmic pattern. In a secondary regulatory loop, the REV-ERB and ROR nuclear receptor families play critical roles in the regulation of Bmal1 expression, thus influencing circadian rhythmicity. Additionally, CK1δ and CK1ε are involved in the post-translational modification of PER and CRY. This phosphorylation process facilitates the subsequent degradation of PER and CRY, thereby maintaining the 24-h circadian cycle Diurnal rhythms in microbial, immune and neural components of the gut microbiota-immune-brain axis Diurnal oscillations of gut microbiota The gut microbiota exhibits diurnal oscillations in its composition [36, 37]. These microbial oscillations are influenced by host circadian signals and feeding schedules. While feeding patterns affect diurnal microbial oscillations, host circadian signals, including hormones and autonomic innervation, also contribute to these diurnal variations [38]. The microbiota and their metabolites influence circadian gene expression in the intestinal epithelium through pattern recognition receptors like toll-like receptors (TLRs) [39]. Microbial metabolites interact with enteroendocrine cells in the intestinal epithelium, influencing the secretion of gut peptides and neurotransmitters, such as including glucagon-like peptide-1 (GLP-1), peptide YY (PYY), and serotonin (5-HT), that can act locally or systemically [40–42] (Fig. 2). This relationship between diurnal rhythms and gut microbiota is bidirectional, as microbial metabolites influence circadian gene expression and metabolic homeostasis [43]. Disruption of circadian rhythms can lead to gut dysbiosis, potentially contributing to metabolic disorders, obesity, and inflammatory diseases [43, 44].Fig. 2The effect of circadian rhythms on gut microbiota, microglia, macrophages, and neurons. A bidirectional relationship between diurnal rhythms and gut microbiota is illustrated, with the involvement of gut microbiota-derived metabolites. Moreover, Bmal1 expression modulates microglial activation, while Rev-erbα expression affects microglial activation by regulating NF-κB signalling, which regulating the release of proinflammatory cytokines. The activation of microglia would further influence amyloid-beta uptake and pro-inflammatory cytokine regulation of microglia. Additionally, Rev-erbα expression affects lipid metabolism in microglia, further affecting tau aggregation and neuroinflammation. In macrophages, circadian rhythms regulate its activation and production of cytokines. In neurons, clock gene expression affects various brain modulation processes, including redox reactions and synaptic activities, underscoring the role of circadian rhythms in the regulation of cognitive functions The effect of circadian rhythms on gut microbiota, microglia, macrophages, and neurons. A bidirectional relationship between diurnal rhythms and gut microbiota is illustrated, with the involvement of gut microbiota-derived metabolites. Moreover, Bmal1 expression modulates microglial activation, while Rev-erbα expression affects microglial activation by regulating NF-κB signalling, which regulating the release of proinflammatory cytokines. The activation of microglia would further influence amyloid-beta uptake and pro-inflammatory cytokine regulation of microglia. Additionally, Rev-erbα expression affects lipid metabolism in microglia, further affecting tau aggregation and neuroinflammation. In macrophages, circadian rhythms regulate its activation and production of cytokines. In neurons, clock gene expression affects various brain modulation processes, including redox reactions and synaptic activities, underscoring the role of circadian rhythms in the regulation of cognitive functions Diurnal rhythms in macrophages Macrophages are peripheral phagocytic immune cells that are key components of the innate immune system. Macrophages possess intrinsic, autonomous circadian clocks that operate even ex vivo [45]. The intrinsic cellular clocks in macrophages regulate the rhythmic production of inflammatory mediators, as demonstrated by time-dependent variations in TNF-α and IL-6 secretion following lipopolysaccharide (LPS) stimulation [45]. The expression of clock genes in macrophages influences the temporal patterns of cytokine production, including interferon-γ (IFN-γ), interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) [46]. Furthermore, deletion of Rev-erbα in mice could enhance LPS-induced neuroinflammation, while its activation suppresses it [47]. This indicates that Rev-erbα contributes to immune suppression and limits macrophage overactivation [47, 48] (Fig. 2). Together, these findings demonstrate that circadian mechanisms play a crucial role in regulating macrophage-mediated immune responses. Diurnal rhythms in microglia Microglia, the primary immune cells of the central nervous system (CNS), exhibit distinct diurnal rhythms. Microglia exhibit diurnal morphological variations. Specifically, during the light phase, microglial processes are reported to be shorter and less branched, whereas during the dark phase, they display greater complexity and length [49]. Microglia display time-dependent variations in their immune functions. During the light phase, microglia exhibit an enhanced cytokine response to LPS treatment [50]. Microglia in Bmal1 knockout mice showed a significant reduction of expressions of inflammation-related genes, such as IL-1β and NADPH oxidase 2 (Nox2). Knockdown of Bmal1 in microglial BV-2 cells also exhibited downregulation of pro-inflammatory IL-1β, TNF-α, and Il-6 gene expressions at 4 h after LPS treatment, indicating circadian regulation of microglia significantly influences pro-inflammatory innate immune system [51].Moreover, deleting Rev-erbα results in spontaneous pro-inflammatory activation of microglia in the hippocampus of C57BL/6 J mice by modulating NF-κB-related genes, thus enhancing basal NF-κB signalling and elevated neuroinflammation responses. When Rev-erbs was activated by the small molecule agonist SR9009, neuroinflammation responses was suppressed [52]. In addition, Lee et al. [53, 54] demonstrated that the deletion of Rev-erbα in microglia resulted in the disruption of lipid metabolism. Overall, these findings establish a link between circadian rhythms, microglial activity and neuroinflammation (Fig. 2). Diurnal rhythms in neurons Neuronal activity exhibits diurnal rhythms that is shaped by both SCN-driven systemic timing cues (sleep–wake state, environment, feeding rhythms) and local, cell-autonomous clocks within neurons across multiple brain regions. Circadian clocks modulate neuronal excitability [55], synaptic transmission and plasticity [56, 57], neurotransmitter release [58], and redox reaction of neurons [59, 60]. Under physiological conditions, inhibitory interneurons exhibit intrinsic diurnal rhythmicity in firing, with peak activity occurring at light–dark transitions, whereas excitatory pyramidal neuron firing remains stable across the 24-h cycle [61]. When circadian rhythm is disrupted, the activity of inhibitory GABAergic neurons is increased [62, 63]. In addition, disruption of circadian rhythms shifts the excitatory/inhibitory balance of synaptic transmission in the dentate gyrus toward inhibition and converts cholinergic responses from disinhibition in normal circadian conditions to increased net inhibition [64]. Overall, these findings are summarised in Fig. 2. Importantly, neuronal rhythmicity is regulated in the context of the gut microbiota–immune–brain axis. Microbiota-derived signals (e.g., short-chain fatty acids), vagal afferent signaling, and immune mediators that fluctuate with feeding and microbial oscillations can tune neuronal set points by altering neuromodulatory tone, synaptic efficacy, and glial–neuronal interactions [65]. Accordingly, circadian disruption can desynchronize host and microbial rhythms, which may further affect the diurnal rhythms in neurons. Association between Circadian Disruption and Neurodegenerative Diseases Aging-related neurodegenerative diseases, including AD and Parkinson’s disease (PD), are a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system. Studies have supported the hypothesis that circadian disruption correlates with neurodegenerative diseases [66–70]. The circadian clock modulates inflammatory responses by regulating astrocyte and immune cell activation, including microglia and macrophages, as well as the release of inflammatory mediators [52, 71]. Disruption of the circadian clock can also lead to chronic low-grade inflammation [48]. Aside from increasing the release of inflammatory mediators, circadian disruption also highly associated with oxidative stress [48] (Fig. 3). Oxidative stress, defined as an imbalance between the production of reactive species, such as ROS and reactive nitrogen species (RNS) and the capacity of antioxidant defenses, is a critical driver of aging and age-related diseases [72]. Circadian clock function is influenced by cell redox status [73, 74], while circadian clock proteins regulate redox homeostasis of cells [48] (Fig. 3). For example, knockout of the circadian gene Per2 altered oscillations and expression of antioxidant enzymes, superoxide dismutase, which could further alter oxidative stress levels in the body [75]. Elevated oxidative stress promotes protein misfolding, mitochondrial malfunction, and neuronal cell apoptosis [76]. It is reported that ROS increases the activity of tau kinases, such as glycogen synthase kinase 3 beta (GSK-3β) and p38, and inhibits tau-dephosphorylating enzyme, such as protein phosphatase 2 A (PP2A), which promotes tau-hyperphosphorylation and aggregation of fibrillary tangles [77–80] In addition to phosphorylated tau aggregation, oxidative stress also α-synuclein aggregation [81, 82]. Oxidative stress both directly and indirectly activates immune cells in the brain which leads to the elevation of cytokines and caused or worsen neuroinflammation [83]. Together, these mechanisms contribute to the progression of AD and PD. Moreover, circadian disruption could also impair the clearance ability of the brain to toxic proteins, such as β-amyloid peptide and tau protein [84–86]. These uncleared toxic proteins aggregate and thus contribute to the progression of AD chronically [48] (Fig. 3). To summarize, these findings strongly indicated how circadian disruption worsen the progression of neurodegenerative diseases.Fig. 3Potential mechanisms linking circadian disruption to neurodegenerative diseases. Circadian rhythms regulate immune responses of astrocytes and immune cells, and further modulate their release of inflammatory mediators, such as cytokines. Circadian disruption induces low-grade inflammation, impairs microglia-mediated clearance of toxic proteins in the brain, and could promote accumulation of amyloid-β plaques and hyperphosphorylated tau. Additionally, circadian disruption increases oxidative stress by reducing antioxidant enzyme activity, further promoting protein aggregation. Together, these mechanisms contribute to the progression of neurodegenerative diseases such as AD and PD Potential mechanisms linking circadian disruption to neurodegenerative diseases. Circadian rhythms regulate immune responses of astrocytes and immune cells, and further modulate their release of inflammatory mediators, such as cytokines. Circadian disruption induces low-grade inflammation, impairs microglia-mediated clearance of toxic proteins in the brain, and could promote accumulation of amyloid-β plaques and hyperphosphorylated tau. Additionally, circadian disruption increases oxidative stress by reducing antioxidant enzyme activity, further promoting protein aggregation. Together, these mechanisms contribute to the progression of neurodegenerative diseases such as AD and PD In AD, the relationship between circadian disruption and disease progression involves retinal pathology. In the retina, specialized melanopsin-containing retinal ganglion cells (mRGCs) transmit light information via the retinohypothalamic tract to the SCN, the control centre of circadian rhythms [87]. AD patients showed reduced light signaling to the SCN, loss of mRGCs, and decreased nerve fiber thickness [87–90], possibly due to retinal accumulation of β-amyloid plaques and phosphorylated tau [91, 92]. The degree of SCN degeneration correlates with the severity of sleep–wake cycle disruption, memory impairment, and metabolic dysfunction [93–96]. Patients with PD also reported a reduced density and morphological changes of mRGCs which led to mRGCs dysfunction [97]. Moreover, α-synuclein buildup in the brain regions which consist of cholinergic, GABAergic, and glutamatergic neurons, which are linked with CRSWD [98–100]. Therefore, patients with neurodegenerative diseases often suffer from CRSWD, which are non-cognitive and non-motor symptoms. In summary, these findings suggested strong association between circadian disruption and neurodegenerative diseases. Relationship between circadian rhythms and immune system Circadian rhythms in immune system regulation The immune system exhibits circadian oscillations that optimize defense against pathogens. At the molecular level, these oscillations are driven by clock genes in the transcriptional-translational feedback loop [101]. Multiple studies have proven that the regulation of circadian rhythms of the immune system is critical for balancing anti-inflammatory and pro-inflammatory signals, preventing chronic inflammation and autoimmune diseases [101–103]. A key mechanism linking immune response to circadian regulation involves REV-ERBα, which acts as a critical mediator of temporal gating in macrophage inflammatory responses. Studies have shown that disruption of REV-ERBα eliminates the circadian control of endotoxin responses, while manipulation of REV-ERBα activity directly modulates pro-inflammatory cytokine production [47]. Meanwhile, the circadian rhythms also influence the gut microbiota and microbial metabolite production, further enhancing its ability to regulate the immune system via various mechanisms. The details of these mechanisms are mentioned in Sect. "Bidirectional relationship between gut microbiome and immune system" of this review. Chronic circadian disruption directly impacts immune system function. Jet lag and shift work can cause chronic circadian disruption in humans. In animal studies, animal models are exposed to repeated phase shifts in light/dark cycles to mimic the chronic circadian disruption in humans. A chronic jet lag model with 6-h phase advance has demonstrated that proinflammatory cytokines, such as IL-1β, GM-CSF, IL-12, TNFα and IL-13, were elevated and decreased anti-inflammatory cytokine IL-10 after LPS challenge [104, 105]. Elevated inflammatory responses were also found in shift workers. Shift workers exhibited significant increase in inflammatory marker C-reactive protein and the cytokines TNF-α, IL-1β, and IL-10 [106–108]. Brain microvascular endothelial cells (BMECs) is one of the cell types forming highly specialized brain endothelial capillaries which build up the blood brain barrier (BBB) [109]. BMECs relate to each other by tight junctions (TJs) and adherens junctions (AJs) [110, 111]. Several studies illustrated that these cytokines decreased the levels of β catenin, which positively correlated to the regulation of TJ proteins expressions, and TJ proteins (claudin, occludin and ZO-1) [112–114]. The loss of TJ proteins is found to be associated with the loss of the TJ integrity of BBB, which leads to BBB breakdown [111, 115–117]. Increased permeability of the BBB enables cytokines to enter the brain, where they activate microglia, the resident immune cells of the CNS, thereby promoting neuroinflammation [118]. These findings demonstrate how circadian disruption can directly alter immune regulation and promote inflammatory processes that may contribute to neurodegeneration. Effects of the immune system on circadian rhythms Various immune factors regulate the circadian system, such as interleukin-1β (IL-1β) and TNF-α. At the molecular level, the transcription factor NF-κB plays a crucial role in this regulation, as evidenced by how its inhibition prevents circadian shifts induced by both LPS and light exposure [119]. In addition, TNF-α, secreted primarily by macrophages and Th1 cells, suppresses E-box-mediated clock gene expression via p38 mitogen-activated protein kinases (p38 MAPK) and a calcium-dependent mechanism,while suppression of this process leads to disruptions in the regular oscillation of clock genes [120, 121]. Overall, these mechanisms establish a bidirectional communication between the immune and circadian systems (Fig. 4).Fig. 4The bidirectional relationship between circadian rhythms and the immune system. It shows a normal relationship between the circadian rhythm and the immune system. Circadian rhythms affect the immune system by changing the gut microbiota composition and short-chain fatty acids (SCFAs) production, which modulate immune cell activity. Thereby influencing the expression of cytokines, chemokines, and cell adhesion molecules. The signaling molecules produced lead to negative regulation of circadian rhythms The bidirectional relationship between circadian rhythms and the immune system. It shows a normal relationship between the circadian rhythm and the immune system. Circadian rhythms affect the immune system by changing the gut microbiota composition and short-chain fatty acids (SCFAs) production, which modulate immune cell activity. Thereby influencing the expression of cytokines, chemokines, and cell adhesion molecules. The signaling molecules produced lead to negative regulation of circadian rhythms The interaction between immune cells and circadian rhythms facilitates effective recovery from infection [119]. However, infection or inflammation can also undermine the effects of circadian rhythms, exacerbating inflammatory response and thus creating a vicious cycle [103]. This relationship is particularly evident in chronic inflammatory conditions such as rheumatoid arthritis and multiple sclerosis, where circadian disruption correlates with enhanced inflammatory responses and disease progression [104]. Microbiome-gut-brain axis Bidirectional relationship between gut microbiome and immune system Gut microbiota communicates with the host via various mechanisms. They might communicate with the host by generating metabolites and signaling molecules and by interacting with the immune system [122]. This communication is fundamental to the gut-brain axis and to overall health maintenance [123, 124]. Disruption of this communication has been linked to various conditions, including gastrointestinal disorders, metabolic diseases, immune dysfunctions, and even neurological conditions [125, 126]. Furthermore, researchers uncover the intricate mechanism by which the gut microbiome impacts human health. For instance, within the gastrointestinal tract, epithelial cells serve as critical sentinels, relaying essential information to immune cells residing in the lamina propria [127]. Indeed, the host immune system and gut microbiome engage in a reciprocal communication. The innate immune system is primarily responsible for recognizing and monitoring gut microbiotas, using pattern recognition receptors (PRRs) such as TLRs and nod-like receptors (NLRs) [128]. These receptors collectively detect pathogen-associated molecular patterns (PAMPs) originating from gut microbiota, such as LPS, peptidoglycans, flagellin, and muramyldipeptide, or danger-associated molecular patterns (DAMPs) arising from damaged tissues [129–134]. The gut microbiota influences the host immune system via TLR–MYD88 signalling, shaping the circadian control of gut lipid metabolism and immunity through two pathways [135]. One pathway is that LPS induces REV-ERBα–HDAC3–NCoR–mediated rhythmic repression of lipid metabolic genes [136]. Another pathway is TLR–MYD88–driven IL-22–STAT3 signaling suppresses REV-ERBα and induces NFIL3, aligning lipid metabolism with immune cell rhythms [137]. This sophisticated detection system enables the gastrointestinal tract, which houses the majority of both microbiota and immune cells, to maintain homeostasis despite continuous exposure to microbial antigens and metabolites, resulting in a balanced host-microbe symbiosis (Fig. 5).Fig. 5The relationship between the microbiome-gut-brain axis and neuroinflammation. Bidirectional communication between the gut microbiota and the brain occurs via various mechanisms, including the production of metabolites and signaling molecules and the interaction with the immune system. An imbalanced gut microbiota generates pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharides (LPS), peptidoglycans, and flagellin, which are recognised by immune cells via pattern recognition receptors. Besides, gut microbiota generates metabolites that induce enteroendocrine cells (EECs) and enterochromaffin cells (ECCs) to produce neurotransmitters and gut hormones. These microbial products, neurotransmitters, and hormones activate vagal afferents, transmitting signals to the central nervous system. This complex interplay of immune, metabolic, and neural signaling demonstrates how gut microbial dysbiosis can initiate and modulate neuroinflammatory responses through multiple mechanisms The relationship between the microbiome-gut-brain axis and neuroinflammation. Bidirectional communication between the gut microbiota and the brain occurs via various mechanisms, including the production of metabolites and signaling molecules and the interaction with the immune system. An imbalanced gut microbiota generates pathogen-associated molecular patterns (PAMPs), such as lipopolysaccharides (LPS), peptidoglycans, and flagellin, which are recognised by immune cells via pattern recognition receptors. Besides, gut microbiota generates metabolites that induce enteroendocrine cells (EECs) and enterochromaffin cells (ECCs) to produce neurotransmitters and gut hormones. These microbial products, neurotransmitters, and hormones activate vagal afferents, transmitting signals to the central nervous system. This complex interplay of immune, metabolic, and neural signaling demonstrates how gut microbial dysbiosis can initiate and modulate neuroinflammatory responses through multiple mechanisms On the other hand, a range of immune responses actively shape the composition and function of the gut microbiota, completing a bidirectional feedback loop. The dominant immunoglobulin class at the mucosal surface-immunoglobulin A (IgA) supports microbiota mutualism. A recent study found that mice’s intestinal IgA production and the transcriptional program of IgA+ plasma cells manifest diurnal rhythms and are regulated by feeding-entrained, and clock gene (Arntl)-dependent circadian control [138]. These rhythmic IgA responses, in turn, drive oscillations in gut microbial composition, thereby maintaining mutualism among the commensal microbiota. Furthermore, tissue-resident immune cells serve as intermediaries between the gut and the brain. Researchers showed that Group 3 innate lymphoid cells (ILC3s) directly regulated by brain circadian circuits, converting light-entrained into enteric ILC3, further influencing gut health, metabolism and microbiome homeostasis [139]. Meanwhile, inflammasomes, such as NLRP6, in intestinal epithelial cells shape microbiome composition by regulating gut colonization [140]. Defective signalling leads to a colitogenic microbiome, while IL-18 secretion prevents such colonisation, influencing susceptibility to inflammatory diseases through alterations in the microbial profile. The field of studying interaction among gut microbiome, the immune system, and the circadian rhythms not only refines a sharper understanding of immunometabolic disease, but also provides novel perspectives for targeted treatment. Role of gut microbiota in neuroinflammation Gut microbiota influences brain function and neuroinflammation through three primary pathways: immune signaling, vagal nerve transmission, and microbial metabolite production. These communication pathways can influence neuroinflammation and brain function with diurnal oscillations in microbial composition in circadian crosstalk. Immune signalling pathways Dysbiosis of the gut microbiota can trigger systemic inflammation [141], which in turn can lead to neuroinflammation [142, 143]. Specific alterations in bacterial taxa composition modulate immune responses and inflammatory pathways that ultimately affect CNS homeostasis. Higher proportions of Escherichia coli and Bacteroides fragilis have also been associated with inflammatory bowel diseases (IBD) [144, 145]. These bacteria are gram-negative and contain LPS to stimulate the expression of several cytokines and chemokines in a TLR4-dependent manner, thereby impacting neuroinflammation [146–148]. The gut microbiota plays a direct role in the production and maintenance of various T cell populations that regulate neuroinflammation, including CD4+CD25+Foxp3+ regulatory T cells (Tregs) in both the intestine and spinal cord, as well as IL-17A–producing CD4+ T cells (Th17) in the CNS [149]. Notably, both T cells and neutrophils exhibit diurnal rhythmicity through regulation of the CXC2 signalling pathway and are sensitive to perturbations in gut microbial composition, with peak trafficking patterns occurring at specific circadian phases [150, 151]. Melatonin is produced primarily by the pineal gland in a circadian manner and is also synthesized in the gut,beyond serving as a systemic timing signal, it can both shape—and be shaped by—the gut microbiota [152–155]. Additionally, melatonin, beyond its role as chrono-biotic, exerts complex effects on the gut-brain axis that are relevant to neuroinflammation. Wei et al. [156] found that rats treated with dextran sulphate sodium (DSS) developed neuroinflammation and liver injury, eventually showing depression-like behaviour. However, oral administration with melatonin suppressed the activation of farnesoid X receptor-fibroblast growth factor 15 (FXR-FGF 15) in the gut and apoptosis signal-regulating kinase 1 (ASK1) in the liver, as well as its downstream p38. Meanwhile, melatonin supplementation increased the abundance of gut microbiota associated with SCFA production and decreased the abundance of gut microbiota associated with bile salt hydrolase activity (157) In AD studies, melatonin may provide prevention and define the progression of AD. It can improve Aβ clearance via glymphatic-lymphatic drainage, blood–brain barrier transport, and degradation pathways, and reduce Aβ-induced neurotoxicity [158, 159]. Melatonin also regulates the gut microbiota, increasing the Firmicutes-to-Bacteroidetes (F/B) ratio and Akkermansia abundance, while decreasing pathogenic gut bacteria [160]. Besides, Gao et al. [161] and Vohra et al. [162] demonstrated that the melatonin administration corrected the reduction in F/B ratio and gut microbiota profiling induced by chrono-disruption, while intestinal tight-junction gene expression was improved, and serum inflammatory markers (TNF-α, IL-6) were reduced [161, 162]. The timing of microbial exposure or infection significantly influences the intensity of the immune response, suggesting that inflammation serves as a crucial intermediary in the modulation of neuroinflammatory outcomes by gut microbiota composition, pathogen challenge, and circadian rhythms. Vagal nerve transmission The vagus nerve serves as a fundamental bidirectional neural pathway connecting gut microbiota to the CNS via both afferent and efferent fibres, mediating distinct aspects of gut-brain communication. Fundamentally, vagal afferent fibres transmit sensory and interoceptive signals from the gastrointestinal tract to the brainstem, where they synapse in the nucleus tractus solitarius (NTS) [163, 164]. Pathophysiological changes in the gut microenvironment are sensed by these vagal afferents, leading to central modulation of immune and inflammatory responses. For example, oral administration of the gram-negative, microaerophilic bacterium Campylobacter jejuni has been shown to activate neurons in the NTS—the first intracranial relay site of vagal afferents—demonstrating direct microbial influence on vagal sensory pathways [165]. Vagal afferent signaling can modulate neuroinflammatory processes by influencing microglial activation states and cytokine production in the CNS [166]. Conversely, the vagal anti-inflammatory reflex is mediated through efferent cholinergic signaling and suppresses peripheral cytokine release and attenuates systemic inflammation that would otherwise compromise BBB integrity and promote neuroinflammation [167]. This bidirectional vagal-gut communication exhibits circadian modulation, with vagal tone and parasympathetic activity displaying diurnal oscillations that influence the temporal dynamics of gut-to-brain immune signaling [168]. The integration of gut microbial signals, vagal transmission, and circadian rhythms thus creates a temporally coordinated system for regulating neuroinflammatory responses based on the prevailing gut microbiota status. Microbial metabolite production Microbial metabolite production represents a third critical mechanism through which gut microbiota influences neuroinflammatory processes. Microbial metabolites, such as short-chain fatty acids (SCFAs), amino acid derivatives, and secondary bile acids, modulate the production of gut hormones and neurotransmitters, which directly impact microglial activation, BBB permeability, and peripheral immune cell function [169–173]. In the gut intestinal track, specifically, enteroendocrine cells (EECs), including enterochromaffin cells (ECCs), produce neurotransmitters such as gamma-aminobutyric acid (GABA) and serotonin (5-HT), as well as gut hormones like glucagon-like peptide-1 (GLP-1), in response to microbial metabolite stimulation to communicate with the brain via an endocrine signaling pathway [174–177]. In PD studies, PD patients consistently show gut dysbiosis and reduced SCFA-producing gut microbiota, which further generate systemic and neural signals that hit motor circuits and cognitive circuits in different ways and at different times [178, 179]. According to research, reduced butyrate signaling is associated with more severe motor impairments, such as bradykinesia or rigidity and faster motor progression [179, 180]. On the other hand, loss of SCFA-producing gut microbiota in PD‑mild cognitive impairment may therefore directly weaken hippocampal function, over and above motor circuit damage [181]. As gut microbiota and circadian rhythms are tightly intertwined, both are clearly altered in PD. Determination of gut microbiota and circadian rhythms may provide a plausible framework for why some patients have predominantly motor symptoms while others show prominent cognitive decline at comparable disease stages. The reason behind gut microbiota influencing neuroinflammatory processes may involve microbial metabolite translocation. Disruptions in circadian rhythm and/or gut microbiota composition can lead to low-grade systemic inflammation, often attributed to compromised gut barrier integrity and subsequent translocation of microbial products into systemic circulation [43]. Meanwhile, changes in gut microbiota composition can alter BBB permeability, thereby enhancing peripheral immune cell trafficking and neuroinflammatory responses. Braniste et al. [182] demonstrated that germ-free mice exhibited significantly higher BBB permeability compared to conventionally bred mice, accompanied by alterations in tight junction proteins—including occludin and claudin-5—in the BBB of germ-free mice. One possible mechanism is that SCFAs—particularly butyrate, propionate, and acetate—exert anti-neuroinflammatory effects by modulating microglial phenotypes, reducing pro-inflammatory cytokine production (including IL-1β, IL-6, and TNF-α), and strengthening the integrity of the BBB tight junctions. These metabolites also influence the hypothalamic–pituitary–adrenal (HPA) axis, a key component of the neuroendocrine system involved in immune, stress, and energy homeostasis [183, 184]. Importantly, the production of SCFAs by gut microbiota exhibits circadian oscillations that parallel diurnal rhythmicity in microbial composition and metabolic activity, further creating temporal coordination between microbial metabolite availability and host immune responsiveness. Given the critical role of the gastrointestinal tract in immune responses and its involvement in circadian regulation, the gut–brain–immune axis presents significant opportunities for therapeutic development targeting neuroinflammation and neurodegeneration through microbiota-based interventions or chronotherapeutic approaches. Roles of circadian rhythms in modulating gut microbiota and neuroinflammation Circadian rhythms, gut microbiota, and inflammatory processes form an intricate network of interactions that significantly impact neurological health. Disruption of circadian rhythms alters gut microbial communities and their metabolite production, which in turn modulates cellular functions and immune responses [185–189]. Disruption in gut microbiota may induce systemic inflammation. In addition, circadian misalignment causes an imbalance secretion between pro-inflammatory cytokines and anti-inflammatory cytokines, resulting in systemic inflammation as well [45]. The activation of immune cells leads to the release of cytokines, which then enter the circulation. These cytokines activate the p38 MAPK signaling pathway [190] and thus compromises the integrity of the BBB, increasing its permeability to inflammatory mediators [191]. The enhanced influx of cytokines into the brain activates microglia and astrocytes [50]. In addition, clock genes play a crucial role in modulating both peripheral and central immune cells, and their dysregulation can exacerbate systemic inflammation, neuroinflammation, and neurodegeneration [47, 48]. Prebiotics and probiotics: modulators of circadian rhythms and neuroinflammation The gut microbiota and the immune system interact through complex circadian-dependent mechanisms, offering opportunities for therapeutic intervention. The gut microbiota, which is regulated by feeding patterns, dietary components, and host circadian rhythms, is critical for sustaining intestinal immunity and metabolic health [192, 193]. Indeed, the gut microbiota and its metabolites can directly influence the circadian gene expression and serve as a mediator between the diet and host circadian rhythmicity [194]. Circadian disruption, such as shfit work and jet lag, can lead to gut dysbiosis and increased susceptibility to gastrointestinal infections [195]. Understanding these intricate relationships has revealed promising therapeutic opportunities by manipulating the microbiota. Prebiotics and probiotics, regarded as a potential chronotherapy, emerge as dietary interventions for alleviating neuroinflammation and neurodegeneration by targeting both circadian rhythm regulation and immune system function. This approach offers novel strategies for developing chronotherapy-based treatments that leverage the gut-brain axis to improve neurological outcomes. Prebiotics act as modulators of circadian rhythms and neuroinflammation Prebiotics are dietary components that are not digested by the human gastrointestinal tract. However, prebiotics could serve as a food source for beneficial bacteria in the gut [196]. These substances selectively stimulate the growth and activity of beneficial bacteria, such as Bifidobacteria and Lactobacilli,therefore, prebiotics can improve the composition and function of the intestinal microbiota [197]. Prebiotics reach the colon intact and are fermented by saccharolytic microbes. This kind of bacteria produces SCFAs, such as acetate and butyrate. SCFAs have various beneficial effects, including acting as a histone deacetylase inhibitor, inhibiting pro-inflammatory cytokines, and influencing the gut-brain axis [94, 95, 198–200]. Our previous study showed that prebiotics treatments, beta-glucan and inulin, can attenuate systemic inflammation-induced neuroinflammation [201], as well as alleviate circadian misalignment and its induced metabolic syndrome by regulating both peripheral and central circadian gene expression in mice via modulation of gut microbiota [202, 203]. This interaction is most probably explained through SCFAs-mediated mechanisms, as acetate and butyrate administration induce distinct changes in circadian gene expression of hepatic organoids [204]. Additionally, prebiotic supplementation facilitates the realignment of sleep and diurnal rhythms following circadian disruption in rats, correlating with alterations in gut bacterial populations and bile acid profiles [205]. Furthermore, prebiotics treatment could improve cognitive function via the gut-brain axis. For example, a 15-week 500 mg/Kg prebiotic treatment with beta-glucan derived from Lentinula edodes could reverse gut microbiome alterations induced by a high-fat diet and protect C57BL/6 J male mice from recognition memory impairment [206]. Novel sources of prebiotics, such as oolong tea polyphenols, demonstrate promising effects on circadian regulation, with the enhancement of beneficial gut microbiota and modulation of metabolic pathways [207]. Another study found that prebiotics treatment, 1 ml/day of a 10% xylooligosaccharide (XOS) diet, ameliorates cognitive dysfunction induced by a high-fat diet via the gut-brain axis in male Wistar rats. The XOS diet prevented gut dysbiosis induced by a high-fat diet, reduced microglial activation, and improved hippocampal plasticity, thereby further enhancing cognitive function [208]. In short, prebiotic treatment is a potential therapeutic strategy in circadian disruption and neuroinflammation. Probiotics act as a modulator of circadian rhythms and neuroinflammation Probiotics are live microorganisms that confer health benefits on the host when administered in adequate amounts [209]. These beneficial bacteria can positively influence the gut microbiota composition and function. Extensive animal studies have demonstrated the neuroprotective effects of probiotics, particularly in reducing neuroinflammation and slowing neurodegeneration (Table 1). The specific probiotic formulation, containing Lactobacillus helveticus r0052 and Bifidobacterium longum r0175, exhibited a protective effect against LPS-induced neuroinflammation in rats, potentially by reducing inflammation, oxidative stress, and memory impairment [210]. In a 3xTG-AD mouse model, LAB4P probiotics, including Lactobacillus acidophilus cul21, Lactobacillus acidophilus cul60, Lactobacillus plantarum cul66, Bifidobacterium bifidum cul20 and Bifidobacterium animalis subsp lactis CUL34, had preventative effects on cognitive decline, neurodegeneration and neuroinflammation in the presence or absence of a metabolic challenge [211]. Moreover, Lab4P probiotics reduced β-amyloid neurotoxicity and protected against neurodegeneration and neuroinflammation in human SH-SY5Y neurons [211]. Similarly, in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of PD, VSL#3 probiotic formulation (consisting of eight cultured bacteria: four Lactobacillus species: L. acidophilus, L. plantarum, L. casei, and L. delbrueckii subsp. bulgaricus,three Bifidobacterium species: B. breve, B. longum, and B. infantis,and Streptococcus salivarius subsp. thermophilus) significantly improved striatal dopamine content, protected dopaminergic neurons, and reduced inflammatory markers (TNF-α and IL-1β mRNA levels) in the striatum and peripheral tissues induced by MPTP [212, 213]. Besides, the impact of a probiotic mixture containing Lactobacillus helveticus and B. longum on neuroinflammation was also studied in a mouse model of AD. The probiotic treatment reduced neuroinflammatory markers and β-amyloid deposition in the brain, thereby improving cognitive function in mice [214]. These preclinical findings demonstrate the therapeutic potential of probiotics as a novel intervention strategy for neuroinflammation and neurodegeneration, warranting further investigation in clinical settings.Table 1The effect of selected probiotics on neurodegenerative diseases from animal and clinical studiesType of studyProbiotics speciesDurationSignificancesRefAnimal studyLactobacillus acidophilus CUL21, Lactobacillus acidophilus CUL60, Lactobacillus plantarum CUL66, Bifidobacterium bifidum CUL20 and Bifidobacterium animalis subsp lactis CUL3424 weeksPreventative effects on cognitive decline, neurodegeneration and neuroinflammation and reduction of β-Amyloid neurotoxicity in 3xTg-AD Alzheimer's disease mice [211]Animal studyLactobacillus acidophilus NCIMB 30175, Lactobacillus plantarum NCIMB 30173, Lactobacillus rhamnosus NCIMB 30174 and Enterococcus faecium NCIMB 3017624 daysImprovement of gut integrity; preventative effect on striatal neuroinflammation, and preventing the loss of tyrosine hydroxylase(TH)-positive neurons by ~ 17% in a rat early-stage Parkinson's disease model [215]Animal studyLactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, Lactobacillus delbrueckii subsp. bulgaricus, Streptococcus thermophiles, Bifidobacterium lactis, and Bifidobacterium breve6 weeksDownregulation of mRNA expression of NOD-like receptor protein 3 (NLRP3) and caspase-1 in brain and peripheral tissues of Parkinson's disease mice, and suppressed the serum level of inflammatory cytokines [212, 213]Animal studyLactobacillus paracasei, Lactobacillus salivarius, together with two strains of Bifidobacteria12 weeksImprovement of cognition in 3xTg-AD Alzheimer's disease mice(211)Animal studyLactobacillus plantarum (ATCC® 8014™) and Bifidobacterium bifidum (ATCC® 29,521)8 weeksUpregulation of brain-derived neurotrophic factor in the hippocampus and improved short-term memory in rats with Alzheimer's disease [216]Animal studyLactobacillus helveticus R0052 and Bifidobacterium longum R017514 daysUpregulation of brain-derived neurotrophic factor expression and reduction of the serum and hippocampal levels of pro-inflammatory cytokines, IL1-β and TNF-α in a lipopolysaccharide rat model [210]Clinical studyLactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus reuteri, and Lactobacillus fermentum12 weeksUpregulation of TGF-β and PPAR-γ and downregulation of inflammatory IL-1, IL-8 and TNF-α in PBMCs [217]Clinical studyLactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus reuteri, and Lactobacillus fermentum12 weeksDecreased high-sensitivity C-reactive protein and malondialdehyde, and increased glutathione levels; Reduced MDS-UPDRS, insulin and insulin resistance [218]Clinical studyLactobacillus acidophilus, Lactobacillus casei, Bifidobacterium. bifidum, and Lactobacillus fermentum12 weeksEnhancement of MMSE scores and beta cell function; Reduction of malondialdehyde levels, C-reactive protein, insulin resistance, and triglycerides(214) Table 1The effect of selected probiotics on neurodegenerative diseases from animal and clinical studiesType of studyProbiotics speciesDurationSignificancesRefAnimal studyLactobacillus acidophilus CUL21, Lactobacillus acidophilus CUL60, Lactobacillus plantarum CUL66, Bifidobacterium bifidum CUL20 and Bifidobacterium animalis subsp lactis CUL3424 weeksPreventative effects on cognitive decline, neurodegeneration and neuroinflammation and reduction of β-Amyloid neurotoxicity in 3xTg-AD Alzheimer's disease mice [211]Animal studyLactobacillus acidophilus NCIMB 30175, Lactobacillus plantarum NCIMB 30173, Lactobacillus rhamnosus NCIMB 30174 and Enterococcus faecium NCIMB 3017624 daysImprovement of gut integrity; preventative effect on striatal neuroinflammation, and preventing the loss of tyrosine hydroxylase(TH)-positive neurons by ~ 17% in a rat early-stage Parkinson's disease model [215]Animal studyLactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, Lactobacillus delbrueckii subsp. bulgaricus, Streptococcus thermophiles, Bifidobacterium lactis, and Bifidobacterium breve6 weeksDownregulation of mRNA expression of NOD-like receptor protein 3 (NLRP3) and caspase-1 in brain and peripheral tissues of Parkinson's disease mice, and suppressed the serum level of inflammatory cytokines [212, 213]Animal studyLactobacillus paracasei, Lactobacillus salivarius, together with two strains of Bifidobacteria12 weeksImprovement of cognition in 3xTg-AD Alzheimer's disease mice(211)Animal studyLactobacillus plantarum (ATCC® 8014™) and Bifidobacterium bifidum (ATCC® 29,521)8 weeksUpregulation of brain-derived neurotrophic factor in the hippocampus and improved short-term memory in rats with Alzheimer's disease [216]Animal studyLactobacillus helveticus R0052 and Bifidobacterium longum R017514 daysUpregulation of brain-derived neurotrophic factor expression and reduction of the serum and hippocampal levels of pro-inflammatory cytokines, IL1-β and TNF-α in a lipopolysaccharide rat model [210]Clinical studyLactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus reuteri, and Lactobacillus fermentum12 weeksUpregulation of TGF-β and PPAR-γ and downregulation of inflammatory IL-1, IL-8 and TNF-α in PBMCs [217]Clinical studyLactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus reuteri, and Lactobacillus fermentum12 weeksDecreased high-sensitivity C-reactive protein and malondialdehyde, and increased glutathione levels; Reduced MDS-UPDRS, insulin and insulin resistance [218]Clinical studyLactobacillus acidophilus, Lactobacillus casei, Bifidobacterium. bifidum, and Lactobacillus fermentum12 weeksEnhancement of MMSE scores and beta cell function; Reduction of malondialdehyde levels, C-reactive protein, insulin resistance, and triglycerides(214) The effect of selected probiotics on neurodegenerative diseases from animal and clinical studies Clinical studies have further validated the beneficial effects of probiotics on attenuating neuroinflammation (Table 1). A few clinical studies have examined probiotics targeting neurodegenerative diseases in human intervention. Probiotic treatment with a combination of B. bifidum, L. acidophilus, Lactobacillus reuteri, and Lactobacillus fermentum significantly modulated inflammatory responses in peripheral blood mononuclear cells, downregulating pro-inflammatory cytokines (IL-1, IL-8, TNF-α) while upregulating anti-inflammatory factors like transforming growth factor beta (TGF-b) and peroxisome proliferator-activated receptor gamma (PPAR-g) compared to the placebo group [217]. These changes were accompanied by improved insulin sensitivity in the probiotic treatment group [217]. The relationship between probiotics and circadian rhythms has emerged as an important consideration. Circadian disruption can induce gut dysbiosis [219]. Probiotics have shown promise in modulating gut microbiota, potentially preventing various degenerative diseases through immunomodulation [220]. The timing of gastrointestinal infections can significantly impact colonization and inflammation levels, emphasizing the importance of circadian regulation in gut immunity [195]. Gut microbial dysbiosis and enteric infections are contributing factors to irritable bowel syndrome (IBS), with disrupted sleep commonly occurring as a comorbidity. In clinical applications, VSL#3 probiotic treatment has improved sleep patterns and reduced symptoms in IBS patients, suggesting a potential role in circadian regulation [221]. While probiotics show promise in treating neuroinflammatory conditions, further research is needed to fully understand their role in modulating both circadian rhythms and neuroinflammation. The temporary nature of probiotic colonization suggests that strategic administration timing and formulation may be crucial for optimizing therapeutic outcomes. Apart from the administration of prebiotics and probiotics, meal timing is also considered a regulatory factor in the change of gut microbial populations [222, 223]. A clinical study revealed that 35% of the gut microbiota were associated with meal timing and overnight fasting duration [222]. Host–microbiota rhythms were disrupted by various factors, such as shift work or irregular meal timing. The disruption reduced the abundance of beneficial gut microbiota and increased circulating pro‑inflammatory mediators [224–227]. Time-restricted feeding (TRF), in which food intake is confined to a consistent daily window (typically 8–12 h), has emerged as a potent intervention for restoring microbial rhythmicity [228]. TRF synchronizes feeding-fasting cycles with the host circadian clock to create predictable temporal patterns of nutrient availability that entrain microbial oscillations, thereby restoring microbial rhythmicity [229]. Besides, TRF modulates the rhythmic secretion of bile acids and antimicrobial peptides, further shaping the intestinal environment and modulating gut microbial taxa [230]. Wang et al. found that TRF affects colonic nutrient substrates and modulates the diurnal fluctuation of the microbiota in an animal study, demonstrating that the intervention alters the temporal availability of fermentable substrates and thereby reshapes microbial metabolic rhythms [226, 227]. These changes are associated with significant reductions in neuroinflammatory markers, including decreased microglial activation, reduced pro-inflammatory cytokine expression, and improved cognitive function in models of Alzheimer's disease and sleep deprivation [231, 232]. Lung cancer mice demonstrated that TRF affects the faecal microbiome metabolome and its diurnal oscillations, suggesting that the benefits of TRF may extend to disease contexts characterized by circadian disruption [233]. Critically, the baseline gut microbiota composition predicts the efficacy of TRF interventions, underscoring the importance of considering individual microbiome profiles [234]. Gut microbiota may undergo dysbiosis as a natural consequence of ageing, thereby increasing the risk of neurodegeneration or neuroinflammation. Ageing-associated dysbiosis presents significant barriers to probiotic colonisation and efficacy. The altered intestinal environment in elderly individuals—characterised by reduced microbial diversity, increased inflammation, and changes in mucus composition—may impair the survival, colonisation, and metabolic activity of probiotic strains [235, 236]. Clinical trials in elderly populations have shown that probiotic effects may be limited to specific bacterial subpopulations and may not produce broad-spectrum changes in microbiome composition or immune function [237]. However, strain-specific approaches and synbiotic formulations-combining prebiotics with probiotics-show promise for overcoming these barriers [238, 239]. Long-term probiotic interventions may also prevent age-related declines in circadian rhythmicity and metabolic homeostasis, suggesting that early and sustained probiotic use may be more effective than late-life interventions [240]. Optimal timing windows likely vary depending on chronotype, age, baseline microbiome composition, and disease context. Individual variability in circadian phenotypes has important implications for chrono-nutritional interventions. The optimal timing of prebiotic or probiotic administration may differ between young and elderly individuals, as ageing is associated with changes in circadian amplitude and phase [240]. Precision probiotics strategies that integrate microbiome-based stratification with circadian phenotyping represent a promising frontier for personalized medicine [241]. Timing of prebiotic or probiotic administration may influence not only immediate metabolic outcomes but also long-term epigenetic programming, with implications for healthy ageing and disease prevention. However, optimal timing windows for prebiotic or probiotic administration require systematic investigation to directly compare their efficacy at different times of day across diverse populations. The development of circadian biomarkers and the integration of multi-omics data will be essential for translating these concepts into clinical studies. Conclusions and future perspectives The regulation of the gut microbiome-immune-brain axis by circadian rhythms represents a critical pathway in neuroinflammation and the progression of neurodegenerative diseases. Despite significant advances, our understanding of key gut microbiota species and their metabolites that influence circadian rhythms remains limited. Meanwhile, age-related dysbiosis presents substantial challenges to probiotic efficacy, highlighting the need for strain-specific, precision-based strategies tailored to individual microbiome profiles. Advanced genomic studies can be conducted to identify different gut microbiota species. Whole-genome sequencing, combined with taxonomic classification and metatranscriptomics, enables the identification of microbiota species that produce beneficial metabolites for circadian regulation and the alleviation of neuroinflammation. These insights could allow the development of more targeted and effective probiotic formulations incorporating essential microbiota species. Although the theoretical basis for circadian-timed administration is strong, empirical evidence on optimising the timing, composition, and delivery of prebiotics and probiotics remains limited, highlighting an important area for future investigation. Further investigation is crucial to elucidate the specific effects of microbial metabolites on circadian rhythms and neuroinflammation. The application of transcriptomic and proteomic approaches can reveal the underlying mechanisms through which these metabolites influence signaling pathways involved in circadian regulation and neuroinflammatory processes. Understanding the temporal dynamics of metabolite production, as well as their interaction with host circadian systems, may provide critical insights for therapeutic timing and efficacy. The translation of these findings into clinical applications represents another critical frontier. The clinical applications include developing chronotherapy-based intervention strategies, optimizing probiotic delivery timing and formulation, and integrating personalized approaches based on individual circadian profiles. The implementation of multi-omics approaches reveals the complex interplay among circadian rhythms, gut microbiota, and neuroinflammation, potentially leading to novel therapeutic strategies to prevent and manage neurodegenerative diseases by targeted manipulation of the gut-brain axis and circadian systems.